Response to cancer immunotherapy may be affected by genes we carry from birth
Long-term stress linked to increased risk of heart attack
10 February 2021The science of siestas: New research reveals the genetic basis for daytime napping
10 February 2021Response to cancer immunotherapy may be affected by genes we carry from birth
For all their importance as a breakthrough treatment, the cancer immunotherapies known as checkpoint inhibitors still only benefit a small minority of patients, perhaps 15 percent across different types of cancer. Moreover, doctors cannot accurately predict which of their patients will respond.
